Family Medicine Doctors in Chestertown, MD Accepting Medicare

6 Family Medicine doctors found. Showing 1 - 6

Frederick William Delboy, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6602 Church Hill Rd, Suite 200, Chestertown, MD 21620 Phone: 410-778-0300    Fax: 410-778-0351

Dr. Patrick Joseph Shanahan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 Speer Rd, Bldg B, Chestertown, MD 21620 Phone: 410-778-9300    Fax: 410-778-9579

Dr. Susan Kosnik Ross, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Brown St Ste 320, Chestertown, MD 21620 Phone: 410-778-1878

Dr. Andrew Scott Ferguson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 Speer Rd, Bldg B, Chestertown, MD 21620 Phone: 410-778-9300    Fax: 410-778-9579

C. Gottfried Baumann, M.D. Family Medicine - Adult Medicine Medicare: Not Enrolled in Medicare Practice Location: 8293 Brices Mill Rd, Chestertown, MD 21620 Phone: 410-778-0920

Dr. Wayne Douglas Benjamin, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6602 Church Hill Rd, 200, Chestertown, MD 21620 Phone: 410-778-0300    Fax: 410-778-0351

News Archive

Vertex announces abstracts from hepatitis C program to be presented at The Liver Meeting

Vertex Pharmaceuticals Incorporated today announced that abstracts from its hepatitis C program, including two late-breaking posters from studies of INCIVEK (telaprevir) tablets and VX-222, were accepted for presentation at The Liver Meeting, the 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco, November 4-8, 2011.

BioLight Life Sciences declares first sale of IOPtiMate system in Hong Kong

BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announces the first sale of an IOPtiMate™ system in Hong Kong.

RBCC's injectable technology poised to improve use of addiction treatment drug

Rainbow Coral Corp. received a boost recently when researchers reported that a medication that could help tens of thousands of alcoholics quit drinking are underused.

Tarsa obtains $10 million senior credit facility to support NDA submission for Ostora tablet

Tarsa Therapeutics, Inc. today announced that it has secured a $10 million senior credit facility from Oxford Finance LLC and Square 1 Bank. The company intends to use the proceeds to support its plans to file a New Drug Application (NDA) with the U.S. Food and Drug Administration for its Ostora tablet for the treatment of postmenopausal osteoporosis, currently targeted for early 2015.

Read more Medical News

› Verified 3 days ago